ID

13610

Beschrijving

Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00615784

Link

https://clinicaltrials.gov/show/NCT00615784

Trefwoorden

Versies (1)
  1. 19-02-16 19-02-16 -
Houder van rechten

CC BY-NC 3.0

Geüploaded op

19 februari 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Acute Myeloid Leukemia NCT00615784

Engels

Eligibility Acute Myeloid Leukemia NCT00615784

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
age >= 18 years
Beschrijving

age >= 18 years

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
confirmed diagnosis of aml as proven by bone marrow biopsy
Beschrijving

confirmed diagnosis of aml as proven by bone marrow biopsy

Datatype

boolean

Alias
UMLS CUI [1]
C0023467
must have received prior induction therapy with conventional chemotherapy and/or mylotarg or otherwise not eligible for conventional chemotherapy
Beschrijving

must have received prior induction therapy with conventional chemotherapy and/or mylotarg or otherwise not eligible for conventional chemotherapy

Datatype

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0876099
ecog performance status of 0-2
Beschrijving

ecog performance status of 0-2

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
recovered from toxicities of prior chemotherapy
Beschrijving

recovered from toxicities of prior chemotherapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C2004454
UMLS CUI [1,2]
C0013221
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of pancreatitis
Beschrijving

history of pancreatitis

Datatype

boolean

Alias
UMLS CUI [1]
C0030305
active alcohol abuse
Beschrijving

active alcohol abuse

Datatype

boolean

Alias
UMLS CUI [1]
C0038586
taken bexarotene in the past
Beschrijving

taken bexarotene in the past

Datatype

boolean

Alias
UMLS CUI [1]
C0765273
wbc > 10,000/ul at time of enrollment
Beschrijving

wbc > 10,000/ul at time of enrollment

Datatype

boolean

Alias
UMLS CUI [1]
C0023508
cytotoxic therapy within the past 14 days other than hydrea, low dose cytarabine or low dose mylotarg
Beschrijving

cytotoxic therapy within the past 14 days other than hydrea, low dose cytarabine or low dose mylotarg

Datatype

boolean

Alias
UMLS CUI [1]
C0677881
UMLS CUI [2]
C0591617
UMLS CUI [3]
C0010711
UMLS CUI [4]
C0876099
significant organ disfunction: total bilirubin > 3x uln, ast or alt >3 x uln, creatinine > 3 mg/dl, on blood pressure supporting medications or mechanical ventilation
Beschrijving

significant organ disfunction: total bilirubin > 3x uln, ast or alt >3 x uln, creatinine > 3 mg/dl, on blood pressure supporting medications or mechanical ventilation

Datatype

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201899
UMLS CUI [5]
C0199470
UMLS CUI [6,1]
C0005823
UMLS CUI [6,2]
C0013227
active participant in any other investigational treatment study for aml
Beschrijving

active participant in any other investigational treatment study for aml

Datatype

boolean

Alias
UMLS CUI [1]
C2348568
life expectancy of less than 1 month
Beschrijving

life expectancy of less than 1 month

Datatype

boolean

Alias
UMLS CUI [1]
C0023671
use of blood growth factors (g-csf, gm-csf, aranesp, erythropoietin, or neumega) within 1 week prior to treatment initiation
Beschrijving

use of blood growth factors (g-csf, gm-csf, aranesp, erythropoietin, or neumega) within 1 week prior to treatment initiation

Datatype

boolean

Alias
UMLS CUI [1]
C0079459
UMLS CUI [2]
C0079460
UMLS CUI [3]
C1134440
UMLS CUI [4]
C0014822
UMLS CUI [5]
C0537668
uncontrolled hyperlipidemia
Beschrijving

uncontrolled hyperlipidemia

Datatype

boolean

Alias
UMLS CUI [1]
C0020473
known history of hiv
Beschrijving

known history of hiv

Datatype

boolean

Alias
UMLS CUI [1]
C0019682
known active cns involvement with aml
Beschrijving

known active cns involvement with aml

Datatype

boolean

Alias
UMLS CUI [1,1]
C0449389
UMLS CUI [1,2]
C0023467
women of childbearing potential or active breast feeding
Beschrijving

women of childbearing potential or active breast feeding

Datatype

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2]
C0006147
Terug naar het begin van de pagina

Similar models

Eligibility Acute Myeloid Leukemia NCT00615784

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
age >= 18 years
boolean
C0001779 (UMLS CUI [1])
aml
Item
confirmed diagnosis of aml as proven by bone marrow biopsy
boolean
C0023467 (UMLS CUI [1])
chemotherapy
Item
must have received prior induction therapy with conventional chemotherapy and/or mylotarg or otherwise not eligible for conventional chemotherapy
boolean
C0392920 (UMLS CUI [1])
C0876099 (UMLS CUI [2])
ecog
Item
ecog performance status of 0-2
boolean
C1520224 (UMLS CUI [1])
recovery from toxicity
Item
recovered from toxicities of prior chemotherapy
boolean
C2004454 (UMLS CUI [1,1])
C0013221 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
pancreatitis
Item
history of pancreatitis
boolean
C0030305 (UMLS CUI [1])
alcohol abuse
Item
active alcohol abuse
boolean
C0038586 (UMLS CUI [1])
bexarotene
Item
taken bexarotene in the past
boolean
C0765273 (UMLS CUI [1])
wbc
Item
wbc > 10,000/ul at time of enrollment
boolean
C0023508 (UMLS CUI [1])
cytotoxic therapy within the past 14 days other than hydrea, low dose cytarabine or low dose mylotarg
Item
cytotoxic therapy within the past 14 days other than hydrea, low dose cytarabine or low dose mylotarg
boolean
C0677881 (UMLS CUI [1])
C0591617 (UMLS CUI [2])
C0010711 (UMLS CUI [3])
C0876099 (UMLS CUI [4])
organ disfunction
Item
significant organ disfunction: total bilirubin > 3x uln, ast or alt >3 x uln, creatinine > 3 mg/dl, on blood pressure supporting medications or mechanical ventilation
boolean
C0201976 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
C0199470 (UMLS CUI [5])
C0005823 (UMLS CUI [6,1])
C0013227 (UMLS CUI [6,2])
participation status
Item
active participant in any other investigational treatment study for aml
boolean
C2348568 (UMLS CUI [1])
life expectancy
Item
life expectancy of less than 1 month
boolean
C0023671 (UMLS CUI [1])
g-csf, gm-csf, aranesp, erythropoietin, or neumega
Item
use of blood growth factors (g-csf, gm-csf, aranesp, erythropoietin, or neumega) within 1 week prior to treatment initiation
boolean
C0079459 (UMLS CUI [1])
C0079460 (UMLS CUI [2])
C1134440 (UMLS CUI [3])
C0014822 (UMLS CUI [4])
C0537668 (UMLS CUI [5])
hyperlipidemia
Item
uncontrolled hyperlipidemia
boolean
C0020473 (UMLS CUI [1])
hiv
Item
known history of hiv
boolean
C0019682 (UMLS CUI [1])
cns involvement
Item
known active cns involvement with aml
boolean
C0449389 (UMLS CUI [1,1])
C0023467 (UMLS CUI [1,2])
childbearing potential or active breast feeding
Item
women of childbearing potential or active breast feeding
boolean
C3831118 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial